Number of the records: 1  

nivolumab

  1. Record numberd000077594
    Date06.06.2025
    TypeM - MESH
    Topical termnivolumab
    Other termSlovak (Pseudonym) BMS-936558
    Slovak (Pseudonym) MDX-1106
    Slovak (Pseudonym) ONO-4538
    Slovak (Pseudonym) Opdivo
    See also(Skutočné meno) antineoplastiká imunologické
    (Skutočné meno) inhibítory imunitných kontrolných bodov
    UDCD12.776.124.486.485.114.224.060.829D12.776.124.790.651.114.224.060.829D12.776.377.715.548.114.224.200.829
    NoteA genetically engineered, fully humanized immunoglobulin G4 monoclonal antibody that binds to the PD-1 RECEPTOR, activating an immune response to tumor cells. It is used as monotherapy or in combination with IPILIMUMAB for the treatment of advanced malignant MELANOMA. It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN'S LYMPHOMA.
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all